ATP-Dependent Persister Formation in Escherichia coli.

Shan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K. · 2017

Read ATP-Dependent Persister Formation in Escherichia coli. by Shan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5296605.txt.

Introduction

Yue Shan, Autumn Brown Gandt, Sarah E. Rowe, Julia P. Deisinger, Brian P. Conlon, and Kim Lewis challenged the standard model of bacterial persisters in mBio in 2017. Persisters are dormant cells that shrug off antibiotics and drive chronic infections that will not clear. The accepted story blamed a stress signal, ppGpp, switching on toxin-antitoxin systems that halt protein production and put cells to sleep.

The team found holes in that story: stresses switched the toxin systems on without raising persister numbers. A reporter gene long used as a persister marker turned out to answer to ATP, the cell's energy currency, as well as to ppGpp. It still marked persisters in cells lacking the ppGpp machinery. Draining ATP with arsenate made cells drug-tolerant directly: low energy slows protein production and shields DNA from fluoroquinolone damage. Persisters, the authors conclude, form when ATP levels vary and antibiotic targets go quiet.

Catalog record

CREATORShan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5296605

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

ATP-Dependent Persister Formation in Escherichia coli By Yue Shan, Autumn Brown Gandt, Sarah E. Rowe, Julia P. Deisinger, Brian P. Conlon, Kim Lewis, Karen Bush Published in: mBio DOI: 10.1128/mBio.02267-16 ABSTRACT ABSTRACT Persisters are dormant variants that form a subpopulation of cells tolerant to antibiotics. Persisters are largely responsible for the recalcitrance of chronic infections to therapy. In Escherichia coli, one widely accepted model of persister formation holds that stochastic accumulation of ppGpp causes activation of the Lon protease that degrades antitoxins; active toxins then inhibit translation, resulting in dormant, drug-tolerant persisters. We found that various stresses induce toxin-antitoxin (TA) expression but that induction of TAs does not necessarily increase persisters. The 16S rRNA promoter rrnB P1 was proposed to be a persister reporter and an indicator of toxin activation regulated by ppGpp. Using fluorescence-activated cell sorting (FACS), we confirmed the enrichment for persisters in the fraction of rrnB P1-gfp dim cells; however, this is independent of toxin-antitoxins. rrnB P1 is coregulated by ppGpp and ATP. We show that rrnB P1 can report persisters in a relA/spoT deletion background, suggesting that rrnB P1 is a persister marker responding to ATP. Consistent with this finding, decreasing the level of ATP by arsenate treatment causes drug tolerance. Lowering ATP slows translation and prevents the formation of DNA double-strand breaks upon fluoroquinolone treatment. We conclude that variation in ATP levels leads to persister formation by decreasing the activity of antibiotic targets. INTRODUCTION Chronic infections are caused mainly by drug-susceptible pathogens but are difficult to eradicate (1). This is particularly true for biofilms, microbial communities that form on indwelling devices or within soft tissues and are protected from the immune system by a layer of exopolymers (2, 3). An increasing body of evidence points to persister cells as the main culprit of drug tolerance. Produced stochastically by all pathogens studied, persisters are multidrug-tolerant phenotypic variants of the wild type (4, 5). In vivo studies have shown that Escherichia coli bacteria causing urinary tract infections (UTIs) form drug-tolerant biofilms within bladder epithelial cells (6, 7). Mutants with elevated levels of persisters (high persister mutants) are common among Pseudomonas aeruginosa isolates from patients with cystic fibrosis (8), among Mycobacterium tuberculosis isolates from patients with tuberculosis (9), and among Candida albicans from patients with oral thrush (10). Persisters were reported in a chronic Staphylococcus aureus mouse infection model (11). These observations link persisters to clinical manifestation of chronic disease. Most of what we know about the mechanism of persister formation comes from the study of E. coli, and toxin-antitoxin (TA) modules have been linked to persister formation. It has been shown that stochastic expression of the HipA kinase, a type II toxin which inhibits protein synthesis by phosphorylating Glu-tRNA synthetase (12, 13), contributes to the formation of persisters (12, 14). Gain of function mutations in hipA produce elevated levels of persisters in vitro, and the same mutants are present in patients with relapsing UTI (14). Stress-induced toxin expression has also been linked to increases in drug tolerance. Fluoroquinolone antibiotics kill cells by stabilizing toxic reaction intermediates, such as double-stranded breaks in DNA generated by DNA gyrase and topoisomerase (15). The main function of SOS is to express DNA repair enzymes, but the same regulatory pathway also turns on production of the type I TisB toxin in a subpopulation of E. coli cells (16). TisB forms an ion channel in the cytoplasmic membrane, decreasing proton motive force and ATP levels, which leads to drug tolerance (16, 17). One important class of toxins that are linked to persisters are the mRNA interferases encoded by type II TA loci (18). Transcriptome analysis revealed that persisters express high levels of mRNA interferases (19, 20). Ectopic expression of these toxins causes multidrug tolerance (19). Stochastic overexpression of the yoeB toxin in individual cells has been reported to protect from ampicillin as well (21). Deleting single interferases does not produce a phenotype in E. coli (22), but the level of persisters was reported to be drastically decreased in a strain with deletions of 10 mRNA interferases (Δ10TA) (23). Stress in the form of starvation has also been linked to the expression of mRNA interferases (24). Specifically, the formation of ppGpp by the stringent response has been reported to cause an increase in persisters in E. coli and P. aeruginosa (25, 26). A recent study showed that ppGpp induces persister formation through the activation of mRNA interferases and linked stress response, toxin-antitoxin systems, and persister formation (21). The induction of mRNA interferases by stress has become a widely accepted model for persister formation in E. coli (27–31). In this study, we found that most stresses induce mRNA interferase expression, but this leads to an increase in the persister level only in the case of the stringent response. The known persister reporter rrnB P1, the promoter of rRNA, senses both ppGpp and ATP. We found that rrnB P1 reports persister levels in Δ10TA and ppGpp0 backgrounds, indicating that it is the variation in the level of ATP that determines the formation of persisters. These findings are consistent with our recent study in the Gram-positive pathogen S. aureus (32) and indicate a universal role of ATP in the drug tolerance of different species. A drop in ATP decreases the activity of antibiotic targets, providing a simple explanation for the mechanism of drug tolerance and persister formation. RESULTS mRNA interferases are upregulated by stress. Certain mRNA interferases are expressed during starvation induced by serine hydroxamate or glucose limitation, and it was suggested that this leads to persister formation (24, 33–36). However, evidence linking the induction of mRNA interferases during stress to persister production is lacking. We sought to determine whether various stresses activate these mRNA interferases and induce persister formation. We screened 10 mRNA interferases for induction of transcription by several stresses, including acid, high sodium, high osmolarity, isoleucine starvation (stringent response), and phosphate starvation. Since the promoters of the TAs are repressed by free antitoxin or toxin-antitoxin complexes, we reasoned that if a toxin is activated, there should be less antitoxin and higher transcription activity. Thus, activation of the promoter indicates an imbalance between toxin and antitoxin (37). E. coli strains from a library of promoter-gfp fusions (38) were used for this purpose. Each stress induces a subset of TAs. Isoleucine starvation induces all 10 TAs, followed by osmotic stress (8 TAs), phosphate stress (6 TAs), acid stress (4 TAs), and NaCl stress (1 TA) (Table 1; see also Fig. S1 in the supplemental material). The levels of stresses we chose were reported to represent physiologically relevant conditions and do not significantly impact growth (see Fig. S2). The induction of 10 TA systems by isoleucine starvation agrees with previous studies and validates our approach (34, 39). 10.1128/mBio.02267-16.1FIG S1 Interferases are differentially upregulated by stress. Interferase promoters driving the expression of gfp were assayed for induction in response to various stress conditions (described in detail in Materials and Methods): isoleucine starvation (A), osmotic stress (B), phosphate starvation (C), acid stress (D), and sodium stress (E). GFP fluorescence (excitation at 485 nm and emission at 528 nm) and optical density (OD600) were recorded every 30 min for 14 h. Background fluorescence was subtracted using a strain carrying a

Read the complete text